The abnormal signaling pathways have emerged as a crucial area of research in the diagnosing and treating of RA, including NF-κB, MAPK, WNT, PI3K/AKT, SYK, and JAK/STAT pathways [21,22,23,24]. Here, NFKB1 is linked to rheumatoid arthritis.